Clinical variability in CILK1-related CED, with differing liver or skeletal predominance, likely reflects genetic modifiers (e.g., IFT122, IFT52, GLI3) or environmental factors, although no explicit pathogenic modifiers were identified in our cohort. The gene discussed is IFT122; the disease is cranioectodermal dysplasia.